About Kupando
KUPANDO is a pioneering Berlin-based biopharmaceutical company developing a TLR 4/7 agonist that stimulates innate immunity.
Our Mission is to provide, not only a safe but also affordable, immunotherapy to cancer patients, and to develop immunostimulatory agents with the means to prevent infectious diseases.
Facts about Kupando
Facts about Kupando
- Founding: 2018
- Focus : Service
- Industry : Biotechnology, Pharma